145 related articles for article (PubMed ID: 38130950)
1. Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn's Disease-A Systematic Review and Network Meta-Analysis.
Attauabi M; Rasmussen DN; Bergenheim FO; Burisch J; Seidelin JB
Crohns Colitis 360; 2023 Oct; 5(4):otad074. PubMed ID: 38130950
[No Abstract] [Full Text] [Related]
2. Authors' Reply to Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn's Disease-A Systematic Review and Network Meta-analysis.
Singh A; Midha V; Kochhar GS; Shen B; Sood A
Crohns Colitis 360; 2023 Oct; 5(4):otad075. PubMed ID: 38130949
[No Abstract] [Full Text] [Related]
3. Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Shehab M; Alrashed F; Heron V; Restellini S; Bessissow T
Inflamm Bowel Dis; 2023 Mar; 29(3):367-375. PubMed ID: 35604382
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab - an effective and promising treatment for patients with fistulizing Crohn's disease: a case series.
Kouklakis G; Efremidou EI; Zezos P; Liratzopoulos N; Souftas VD; Gatopoulou A; Simopoulos K; Manolas KJ
J Med Case Rep; 2011 Mar; 5():109. PubMed ID: 21418588
[TBL] [Abstract][Full Text] [Related]
5. Review article: Medical therapy for fistulizing Crohn's disease.
Bressler B; Sands BE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature.
Attauabi M; Burisch J; Seidelin JB
Scand J Gastroenterol; 2021 Jan; 56(1):53-58. PubMed ID: 33264569
[TBL] [Abstract][Full Text] [Related]
7. Treatment of fistulizing Crohn's disease.
Lichtenstein GR
Gastroenterology; 2000 Oct; 119(4):1132-47. PubMed ID: 11040200
[TBL] [Abstract][Full Text] [Related]
8. Management of Perianal Fistulizing Crohn's Disease.
Singh A; Midha V; Kochhar GS; Shen B; Sood A
Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37672347
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
Aliment Pharmacol Ther; 2005 Oct; 22(7):613-26. PubMed ID: 16181301
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
[TBL] [Abstract][Full Text] [Related]
11. Remicade does not abolish the need for surgery in fistulizing Crohn's disease.
Poritz LS; Rowe WA; Koltun WA
Dis Colon Rectum; 2002 Jun; 45(6):771-5. PubMed ID: 12072629
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
13. Fistula response to methotrexate in Crohn's disease: a case series.
Mahadevan U; Marion JF; Present DH
Aliment Pharmacol Ther; 2003 Nov; 18(10):1003-8. PubMed ID: 14616166
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn's Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons.
Williams P; Klersy C; Karki C; Bennett D; Rodríguez AM; Ciccocioppo R
Adv Ther; 2022 Jun; 39(6):2761-2777. PubMed ID: 35426592
[TBL] [Abstract][Full Text] [Related]
15. Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis.
Zaboli P; Abdollahi M; Mozaffari S; Nikfar S
J Res Pharm Pract; 2017; 6(3):135-144. PubMed ID: 29026838
[TBL] [Abstract][Full Text] [Related]
16. The analysis of clinico-pathologic characteristics in patients who underwent surgery due to stricturing and non-perineal fistulizing forms of Crohn's disease: a retrospective cohort study.
Cayci M; Bostanci EB; Turhan N; Karaman K; Dalgic T; Ozer I; Ercan M; Ulas M; Akoglu M
Int J Surg; 2015 Mar; 15():49-54. PubMed ID: 25647540
[TBL] [Abstract][Full Text] [Related]
17. FISTULIZING PERIANAL CROHN'S DISEASE: IS THE PATIENT'S SEX A BURDEN? A SYSTEMATIC REVIEW.
Rosevics L; Savio MC; Lima Júnior E; Ramos Júnior O
Arq Gastroenterol; 2023; 60(4):490-524. PubMed ID: 38018554
[TBL] [Abstract][Full Text] [Related]
18. The role of topical therapy for perianal fistulizing Crohn's disease: are we forgetting something?
Ribaldone DG; Resegotti A; Pellicano R; Astegiano M; Saracco GM; Morino M
Minerva Gastroenterol Dietol; 2019 Jun; 65(2):130-135. PubMed ID: 30759975
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
Plamondon S; Ng SC; Kamm MA
Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease.
Magno P; Jiménez CE; Ortiz Z; Torres EA
P R Health Sci J; 2010 Mar; 29(1):60-5. PubMed ID: 20222336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
